FDA Approves First Olmesartan Generics

OCTOBER 27, 2016
Jennifer Barrett, Assistant Editor
The FDA has approved the first generic versions of 4 drugs―Benicar tablets, Benicar HCT tabets, Azor tablets, and Tribenzor tablets―that contain the widely used blood pressure-lowering medication olmesartan medoxomil.
 
The drugs combine olmesartan medoxomil in 1 pill with blood pressure medications amlodipine besylate and hydrochlorothiazide. They are indicated for patients who require multiple blood pressure medications. All 4 drugs are available for oral use in several dosages.
 
Olmesartan medoxomil is an angiotensin-2 receptor blocker that contains a boxed warning about risks of injury or death to a developing fetus during pregnancy.
 
The FDA announced the generics’ approval on October 26.  


SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.